PRINCETON N.J. Dec. 16 2016 PRNewswire Soligenix Inc. Nasdaq SNGX a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today the closing of its previ...
↧